Defining an optimal cut-off point for reticulocyte hemoglobin as a marker for iron deficiency anemia: An ROC analysis
Marah Alzubi(University of Jordan), Abdalla Awidi(University of Jordan), Hisham Bawaneh(Jordan Hospital), Mai AlAdwan(University of Jordan), Alaa Al-Shorman(University of Jordan), Yazan Hamadneh(University of Jordan), Jawad Alrawabdeh(University of Jordan), Mahmoud Odeh(University of Jordan), Nada Odeh(University of Jordan)
Cited by 6
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123